SCHEMBL677918

SCHEMBL677918

CC(Cc1ccc(C#N)cc1)[Sb](C)C

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.50
LOXL2 Q9Y4K0 2/20 0.47
CYP19A1 P11511 5/20 0.42
ALDH1A1 P00352 1/20 0.40
MAOB P27338 4/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KCNJ1 P48048 1/20 0.38
KCNH2 Q12809 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
MAOA P21397 2/20 0.37
IDO1 P14902 2/20 0.37
ALOX5AP P20292 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320821 0.79 CYP2A6 (0.58) CYP2A6LOXL2CYP19A1ALDH1A1MAOB
SCHEMBL7981021 0.76 LOXL2 (0.59) CYP2A6LOXL2SLC6A2SLC6A4MAOA
SCHEMBL21316515 0.76 CYP2A6 (0.54) CYP2A6LOXL2CYP19A1ALDH1A1MAOB
SCHEMBL11198753 0.76 CYP2A6 (0.54) CYP2A6LOXL2CYP19A1ALDH1A1MAOB
SCHEMBL3945082 0.76 CYP2A6 (0.54) CYP2A6LOXL2CYP19A1ALDH1A1MAOB
SCHEMBL18930594 0.76 LOXL2 (0.59) CYP2A6LOXL2SLC6A2SLC6A4MAOA
SCHEMBL2330187 0.76 CYP2A6 (0.54) CYP2A6LOXL2CYP19A1ALDH1A1MAOB
SCHEMBL14051455 0.76 LOXL2 (0.59) CYP2A6LOXL2SLC6A2SLC6A4MAOA
SCHEMBL19354446 0.76 CYP2A6 (0.54) CYP2A6LOXL2CYP19A1ALDH1A1MAOB
SCHEMBL379566 0.76 CYP2A6 (0.54) CYP2A6LOXL2CYP19A1ALDH1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275774-A1 ORGANOANTIMONY COMPOUND, PROCESS FOR PREPARING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH USE OF SAME, AND THE POLYMER YAMAGO SHIGERU 2011-11-10 US disclosed
US-8008414-B2 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2011-08-30 US disclosed
EP-1767539-B1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL CO LTD (JP) 2011-07-27 EP disclosed
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
EP-1767539-A1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL COMPANY, LTD. (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer AOC2, ODC1, MCM7 CYP2A6 1154/4885LOXL2 468/4885CYP19A1 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.